%PDF-1.4
%
3 0 obj
<>>>/BBox[0 0 595.28 841.89]/Length 132>>stream
xͱ
0=Oq&A ŀ[EA'&Ik抶H^r_ηa[X7`1 MWyL͝T!F\dHipsN1:xEՃV_9ç#1QF=?c5%N
endstream
endobj
4 0 obj
<>>>/BBox[0 0 595.28 841.89]/Length 132>>stream
xͱ
0=Oq&A ŀ[EA'&Ik抶H^r_ηa[X7`1 MWyL͝T!F\dHipsN1:xEՃV_9ç#1QF=?c5%N
endstream
endobj
10 0 obj
<>>>/BBox[0 0 595.28 841.89]/Length 132>>stream
xͱ
0=Oq&A ŀ[EA'&Ik抶H^r_ηa[X7`1 MWyL͝T!F\dHipsN1:xEՃV_9ç#1QF=?c5%N
endstream
endobj
6 0 obj
<>>>/BBox[0 0 595.28 841.89]/Length 132>>stream
xͱ
0=Oq&A ŀ[EA'&Ik抶H^r_ηa[X7`1 MWyL͝T!F\dHipsN1:xEՃV_9ç#1QF=?c5%N
endstream
endobj
9 0 obj
<>>>/BBox[0 0 595.28 841.89]/Length 132>>stream
xͱ
0=Oq&A ŀ[EA'&Ik抶H^r_ηa[X7`1 MWyL͝T!F\dHipsN1:xEՃV_9ç#1QF=?c5%N
endstream
endobj
7 0 obj
<>>>/BBox[0 0 595.28 841.89]/Length 132>>stream
xͱ
0=Oq&A ŀ[EA'&Ik抶H^r_ηa[X7`1 MWyL͝T!F\dHipsN1:xEՃV_9ç#1QF=?c5%N
endstream
endobj
8 0 obj
<>>>/BBox[0 0 595.28 841.89]/Length 132>>stream
xͱ
0=Oq&A ŀ[EA'&Ik抶H^r_ηa[X7`1 MWyL͝T!F\dHipsN1:xEՃV_9ç#1QF=?c5%N
endstream
endobj
1 0 obj
<>>>/BBox[0 0 595.28 841.89]/Length 132>>stream
xͱ
0=Oq&A ŀ[EA'&Ik抶H^r_ηa[X7`1 MWyL͝T!F\dHipsN1:xEՃV_9ç#1QF=?c5%N
endstream
endobj
5 0 obj
<>>>/BBox[0 0 595.28 841.89]/Length 132>>stream
xͱ
0=Oq&A ŀ[EA'&Ik抶H^r_ηa[X7`1 MWyL͝T!F\dHipsN1:xEՃV_9ç#1QF=?c5%N
endstream
endobj
12 0 obj
<>stream
application/pdf
10.1080/16549716.2017.1329968
en
Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau
Stine Byberg
Ane Bærent Fisker
Sanne Marie Thysen
Amabelia Rodrigues
Ulrika Enemark
Peter Aaby
Christine Stabell Benn
Ulla Kou Griffiths
Taylor & Francis
Global Health Action, 2017. doi:10.1080/16549716.2017.1329968
Measles vaccine
cost-effectiveness
non-specific effects
barriers to vaccination
Journal
Global Health Action
© 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
1654-9716
1654-9880
10
1
10.1080/16549716.2017.1329968
https://doi.org/10.1080/16549716.2017.1329968
VoR
2017-06-04T05:46:58+05:30
Arbortext Advanced Print Publisher 11.0.3352/W Unicode
2017-08-10T06:47:16-07:00
2017-08-10T06:47:16-07:00
Measles vaccine; cost-effectiveness; non-specific effects; barriers to vaccination
iText 4.2.0 by 1T3XT
uuid:e6b3248f-0dbb-4d39-8fc4-dff751558d0d
uuid:7e33bbf1-5a90-46d8-a097-437d85bb2fa4
2017-06-05truewww.tandfonline.com10.1080/16549716.2017.1329968www.tandfonline.comtrue2017-06-0510.1080/16549716.2017.1329968
endstream
endobj
13 0 obj
<>stream
x+ |
endstream
endobj
14 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
15 0 obj
<>stream
x+ |
endstream
endobj
16 0 obj
<>stream
xS**T0T0 Bi ye(
endstream
endobj
17 0 obj
<>stream
x+ |
endstream
endobj
18 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
19 0 obj
<>stream
x+ |
endstream
endobj
20 0 obj
<>stream
xS**T0T0 Bi y+
endstream
endobj
21 0 obj
<>stream
x+ |
endstream
endobj
22 0 obj
<>stream
xS*
R
endstream
endobj
23 0 obj
<>stream
x+ |
endstream
endobj
24 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
25 0 obj
<>stream
x+ |
endstream
endobj
26 0 obj
<>stream
xS**T0T0 Bi yn)
endstream
endobj
27 0 obj
<>stream
x+ |
endstream
endobj
28 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
29 0 obj
<>stream
x+ |
endstream
endobj
30 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
31 0 obj
<>stream
x+ |
endstream
endobj
32 0 obj
<>stream
xS**T0T0 Bi yw*
endstream
endobj
34 0 obj
<>stream
xZI_/@0MHn`%;F%OUd/otFY,Uu;Xek)k߶TI'z`/7`UU/_X]5އZ)Oxkb;ӝJUS{;۞gDs&8ޤ˿Lb NnjV݈D$Xw*93!69{j[e-BZ1J|uuiZRx|JYXǺ&K0IbQ%W_4W?xoc&34è4
:'F~o/LgTk!AgSVOgI$xFۈOMXe{}xC6,.{<Ěu:kSc
Q5gd43ϕ .?m# e.HhȶjYGzTB6ljG]PmepȺg(@D\p"-@:9ftڎ憄vt+wޛþ3+r&}+yk[y>Uܴ :z`anx
`^Sfz܍rLpZL]'ߍ5Erzg65`y
aVw pӭPsQRlyC$T0`3瑡IdxpXqFv(.\ݕ e |i >Fʀ^,3'6%MTu|~i@F1%ezR<Au̡1,}ڵEiS+TMѷ["8]"FG%zS֗vyiƥ̟n1
C,|/?t~VNq0L+~G{R@S=GJ@`%iѪo+4, fydAsecΨ@vqg`jfm0ӽonU#7mwũSe͛spP&od,,EYy0XTY/-LX\(y,vqnDN8h9d@腟ϲF#E,ǭSvcăm*vHmJ婭QwmwF㯃kJl)8V9μ
P6S$&X;W.-`y9cT
Pٱ !' Xr\r۸ڴv!Hi/XW\O͚
qB=7#1Olh;&^ ۍc+a5VNe/͉nur@
@-3B
oyr A:Vf~Xa<ۨb
_ KHc7}
ny%aDuk F뱲 hݭF|.<~D{$VyY
dmuK"a8Jݬ,gX-?Yv+6Y)